UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~November~~January 1327, ~~2025~~2026

CALIX, INC.

(Exact name of Registrant as specified in its charter)

Delaware

001-34674

68-0438710

(State or other jurisdiction
of incorporation)

(Commission
File No.)

(I.R.S. Employer
Identification No.)

3155 Olsen Drive, Suite 450, San Jose, California

95117

(Address of principal executive offices)

(Zip Code)


(408) 514-3000
(Registrant’s telephone number, including area code)


Not Applicable
(Former name or former address if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

Common Stock, par value $0.025 per share

CALX

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).


Emerging Growth Company						☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act). o

Item 58.0201 ~~Departure~~Other ~~of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Events.

~~(c)~~The OnCompany ~~November~~maintains ~~13,~~a ~~2025,~~repurchase ~~the~~program ~~Board~~for ofits ~~Directors~~common ~~of Calix, Inc~~stock. ~~(the~~As ~~“Company”)~~of ~~appointed~~December ~~John Durocher~~31, ~~age 58~~2025, to the ~~position~~remaining ofauthorized ~~Chief~~balance ~~Operating~~under ~~Officer of~~ the ~~Company~~program ~~effective~~was ~~November 16, 2025~~$109.3 Mrmillion. ~~Durocher~~On ~~has~~January ~~served~~27, as2026, the ~~Company’s~~Board ~~Chief~~amended ~~Customer~~the ~~Officer~~stock ~~since~~repurchase ~~joining~~program ~~Calix in March 2023. Prior~~ to ~~joining~~authorize ~~Calix,~~the ~~Mr.~~repurchase ~~Durocher~~of ~~served~~up asto ~~Executive~~an ~~Vice~~additional ~~President,~~$125 ~~Customer~~million ~~Success~~of atits ~~Salesforce~~common ~~Inc. from 2006 to February 2023. Before joining Salesforce~~stock, ~~Mr.~~bringing ~~Durocher~~the ~~served~~total ~~with~~authorization ~~Accenture~~under ~~Plc on~~ the ~~CRM~~program ~~Service~~up ~~Line.~~to ~~Mr.~~$425 ~~Durocher holds a Bachelor of Arts from Clarkson University~~million.

~~Mr.~~Under ~~Durocher’s~~the ~~compensation~~repurchase ~~remains~~program, ~~unchanged~~repurchases can be made from ~~his~~time ~~prior~~to ~~role~~time using a variety of methods, which may include open market purchases, privately negotiated transactions or otherwise, all in accordance with the rules of the SEC and other applicable legal requirements. The specific timing, price and size of the purchases will ~~continue~~depend ~~under~~on prevailing stock prices, general economic and market conditions, and other considerations consistent with the Company’s ~~existing~~capital ~~executive~~allocation ~~compensation~~strategy. The repurchase program, asdoes ~~disclosed~~not inobligate the Company’s ~~definitive~~to ~~proxy~~acquire ~~statement~~a onparticular ~~Schedule~~amount ~~14A~~of ~~filed~~common ~~with~~stock, and the ~~United~~repurchase ~~States~~program ~~Securities~~may ~~and~~be ~~Exchange~~suspended ~~Commission~~or ondiscontinued ~~March~~at ~~27,~~any ~~2025~~time at the Company’s discretion.

Item 7.01 Regulation FD Disclosure.

A copy of the Company's press release dated November 17, 2025 announcing the appointment is furnished as Exhibit 99.1 to the Current Report on Form 8-K and is incorporated by reference. Such information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.						Description
99.1						Press Release dated ~~November~~January 1728, ~~2025~~2026, announcing increase in stock repurchase authorization.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:

~~November~~January 1728, ~~2025~~2026

Calix, Inc.

By:

/s/ Doug McNitt

Doug McNitt

EVP, General Counsel

Filing Compare · CALIX, INC